Kristian Humer
CIK: 0001872280
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Dec 9, 2025FDMT
4D Molecular Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
480K shares- - May 21, 2025SNSE
Sensei Biotherapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
19K shares- - Jan 22, 2025FHTX
Foghorn Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
120K shares at avg. $4.37-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 9, 2025 |  FDMT 4D Molecular Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 480,000 | - | - | Direct |
| May 21, 2025 |  SNSE Sensei Biotherapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 19,000 | - | - | Direct |
| Jan 22, 2025 |  FHTX Foghorn Therapeutics Inc. | Award(A) Stock Option (right to buy) | 120,000 | $4.37 | - | Direct |
1-3 of 3 transactions
About Humer Kristian
Humer Kristian (SEC CIK 0001872280) files insider reports with the SEC as Chief Financial Officer of 4D Molecular Therapeutics, Inc. (FDMT), Chief Financial Officer of Foghorn Therapeutics Inc. (FHTX) and Director of Sensei Biotherapeutics, Inc. (SNSE).
Signal8 holds 5 ownership filings by Humer Kristian (1 Form 3, 4 Form 4), filed between Jan 24, 2025 and Dec 11, 2025. Those filings report 3 transactions, from Jan 22, 2025 to Dec 9, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Humer Kristian's filings is in CAMBRIDGE, MA.
Recent filings by Humer Kristian
Other insiders filing for 4D Molecular Therapeutics, Inc. (FDMT)
- Bizily Scott, Chief Legal Officer
- Kirn David
- Tomasello Shawn, Director
- THEUER CHARLES, Director
- Miller-Rich Nancy, Director
- GRAY SUSANNAH, Director